BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 16862180)

  • 1. Akt regulates nuclear/cytoplasmic localization of tuberin.
    Rosner M; Freilinger A; Hengstschläger M
    Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin.
    Habib SL; Yadav A; Mahimainathan L; Valente AJ
    Genes Cancer; 2011 Nov; 2(11):1051-60. PubMed ID: 22737271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging.
    Yadav RB; Burgos P; Parker AW; Iadevaia V; Proud CG; Allen RA; O'Connell JP; Jeshtadi A; Stubbs CD; Botchway SW
    BMC Cell Biol; 2013 Jan; 14():3. PubMed ID: 23311891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia and Hyperlipidemia with Kidney or Liver Transplantation: A Review.
    D'Elia JA; Weinrauch LA
    Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Protein Synthesis; The Multifaceted Roles of Tuberin in Cell Cycle Regulation.
    Fidalgo da Silva E; Fong J; Roye-Azar A; Nadi A; Drouillard C; Pillon A; Porter LA
    Front Cell Dev Biol; 2021; 9():806521. PubMed ID: 35096832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.
    Karajannis MA; Mauguen A; Maloku E; Xu Q; Dunbar EM; Plotkin SR; Yaffee A; Wang S; Roland JT; Sen C; Placantonakis DG; Golfinos JG; Allen JC; Vitanza NA; Chiriboga LA; Schneider RJ; Deng J; Neubert TA; Goldberg JD; Zagzag D; Giancotti FG; Blakeley JO
    Mol Cancer Ther; 2021 Sep; 20(9):1584-1591. PubMed ID: 34224367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.
    Li G; Kidd J; Li PL
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer.
    Adimonye A; Stankiewicz E; La-Touche S; Kudahetti S; Trevisan G; Tinwell B; Corbishley C; Lu YJ; Watkin N; Berney D
    PLoS One; 2018; 13(6):e0198905. PubMed ID: 29902261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Pathways in Cancer and Autophagy.
    Paquette M; El-Houjeiri L; Pause A
    Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29329237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.
    Vadla R; Haldar D
    Cell Cycle; 2018; 17(1):110-123. PubMed ID: 29143563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of tuberin in carcinogenesis.
    Jin M; An Q; Wang L
    Oncol Lett; 2017 Sep; 14(3):2598-2602. PubMed ID: 28928805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mTOR Inhibitors in Kidney Disease.
    Kajiwara M; Masuda S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHEB1 expression in embryonic and postnatal mouse.
    Tian Q; Smart JL; Clement JH; Wang Y; Derkatch A; Schubert H; Danilchik MV; Marks DL; Fedorov LM
    Histochem Cell Biol; 2016 May; 145(5):561-72. PubMed ID: 26708151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant AKT1-E17K is oncogenic in lung epithelial cells.
    De Marco C; Malanga D; Rinaldo N; De Vita F; Scrima M; Lovisa S; Fabris L; Carriero MV; Franco R; Rizzuto A; Baldassarre G; Viglietto G
    Oncotarget; 2015 Nov; 6(37):39634-50. PubMed ID: 26053093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).
    Tsang SH; Chan L; Tsai YT; Wu WH; Hsu CW; Yang J; Tosi J; Wert KJ; Davis RJ; Mahajan VB
    Trans Am Ophthalmol Soc; 2014 Jul; 112():103-15. PubMed ID: 25646031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin.
    Pradhan SA; Rather MI; Tiwari A; Bhat VK; Kumar A
    Nucleic Acids Res; 2014 Jun; 42(10):6243-55. PubMed ID: 24748662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where is mTOR and what is it doing there?
    Betz C; Hall MN
    J Cell Biol; 2013 Nov; 203(4):563-74. PubMed ID: 24385483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.
    Zhang J; Kim J; Alexander A; Cai S; Tripathi DN; Dere R; Tee AR; Tait-Mulder J; Di Nardo A; Han JM; Kwiatkowski E; Dunlop EA; Dodd KM; Folkerth RD; Faust PL; Kastan MB; Sahin M; Walker CL
    Nat Cell Biol; 2013 Oct; 15(10):1186-96. PubMed ID: 23955302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.
    Rosner M; Schipany K; Hengstschläger M
    Nat Protoc; 2013 Mar; 8(3):602-26. PubMed ID: 23449254
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.